Search research articles
Contact Us
Filters
Showing results (111-120 of 116) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 116 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report
S M Chang, J G Kuhn, J Rizzo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 1, 2003
Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma
A Bakhshandeh, I Bruns, A Traynor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients
H I Robins, D Rushing, M Kutz, et al.
Cancer Chemotherapy and Pharmacology
|
April 1, 1999
A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia
H I Robins, D M Katschinski, W Longo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 30, 2001
A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer
A M Westermann, E A Grosen, D M Katschinski, et al.
Oncology
|
May 22, 2003
A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma
A M Westermann, G J Wiedemann, E Jager, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 116) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 116 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report
S M Chang, J G Kuhn, J Rizzo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 1, 2003
Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma
A Bakhshandeh, I Bruns, A Traynor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients
H I Robins, D Rushing, M Kutz, et al.
Cancer Chemotherapy and Pharmacology
|
April 1, 1999
A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia
H I Robins, D M Katschinski, W Longo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 30, 2001
A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer
A M Westermann, E A Grosen, D M Katschinski, et al.
Oncology
|
May 22, 2003
A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma
A M Westermann, G J Wiedemann, E Jager, et al.
Page
of 12